March 26, 2003
Forest Pharmaceuticals Has Recalled
The Food and Drug
Administration (FDA) has released the following information.
Thyrolar 1/4 (liotrix tablets, USP), (Liothyronine sodium (T3) 3.1mcg and
Levothyroxine sodium (T4) 12.5mcg, 100-tablet bottles, Rx only. Recall #
Lot #60135, Exp. 06/2003.
Forest Pharmaceuticals, Inc., Earth City, MO, by letters on October 24,
2002. Firm initiated recall is ongoing.
Superpotent; excessive tablet weight specification limits.
VOLUME OF PRODUCT IN COMMERCE